MPS Limited Reports Record FY26 Results: Revenue ₹768 Cr, EBITDA ₹236 Cr, EPS ₹102.11
MPS Limited reported record FY26 results with revenue at ₹768.37 crore and EBITDA at ₹236 crore, up 11.8% YoY. FY26 Basic EPS reached ₹102.11, a 16.3% increase. The company forecasts FY27 EBITDA to exceed ₹300 crore. Q4 FY26 revenue grew 12.66% YoY to ₹205.16 crore, with EBITDA up 20.53%.
The announcement details record financial performance and provides a positive future outlook with specific EBITDA targets, which are material information for investors and significantly impact the company's valuation and investor sentiment.
The company reported record financial results for FY26, including historical high EPS and strong EBITDA growth, along with a positive outlook for FY27. This indicates strong financial health and growth prospects.
MPS Limited announced its audited financial results for the fourth quarter (Q4) and the financial year ended March 31, 2026. The company reported a record EBITDA of ₹236 crore for FY26, a 11.8% year-on-year increase. Revenue for FY26 stood at ₹76,837 lakh (₹768.37 crore), up 5.71% from the previous year. Basic Earnings Per Share (EPS) for FY26 reached a historic high of ₹102.11, marking a 16.3% year-on-year growth.
The company also provided guidance for FY27, projecting EBITDA to comfortably cross ₹300 crore. This growth is expected to be driven by a compound annual growth rate (CAGR) of approximately 21% from FY24 to FY27. The company aims to achieve this through a multi-pronged growth strategy focusing on go-to-market, account depth, new customer acquisition, platform development, and strategic mergers and acquisitions.
In Q4 FY26, MPS Limited reported revenue of ₹20,516 lakh, a 12.66% increase year-on-year. EBITDA for the quarter rose by 20.53% to ₹6,751 lakh, with an EBITDA margin of 32.90%. Profit After Tax (PAT) for Q4 FY26 was ₹4,704 lakh, a 32.51% increase quarter-on-quarter. The company highlighted strong performance across its segments, with Research Solutions revenue growing by 23.04% YoY (ex-AJE) and Education Solutions revenue increasing by 30.55% YoY, boosted by the acquisition of Unbound Medicine.
What to do with a filing like this
MPS Limited filed this with the NSE as a statutory disclosure, categorised under annual results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by MPS Limited. Read the original for the full detail.